Halozyme Announces FDA Approval of argenx's VYVGART ® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE ® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating
Source link
Halozyme Announces FDA Approval of argenx's VYVGART ® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE ® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating
Source link